Aurora Cannabis Inc.

TSX:ACB.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$6.31 +0.48%

+$0.02 today

Market cap
$414.85M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $3.77High $9.33

Volume 0.32M

Average 0.42M

ACB.TO Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Aurora Cannabis Inc.TSX: ACB.TO

Other Income / Expenses · Q4 FY2026 · quarter ended Mar 2026

Other income / expenses grows, but more slowly than its trailing trend

Q4 FY2026 other income / expenses of CA$36.53M rose 251.1% year over year, behind the +521.3% change in trailing-twelve-month other income / expenses. Sequentially, it rose 5.4% from the prior quarter.

Context

  • Other income / expenses amounted to 33.1% of revenue in FY2026, up 28.7 pp from a year earlier.
  • Other income / expenses increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +251.1% toward the trailing-twelve-month pace of +521.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$36.53M+5.4% QoQ
Last fiscal yearMar 2026
CA$106.27M+588.5% YoY
LTMMar 2026
CA$95.89M+521.3% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+251.1%——
1 year+588.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

CAD · from the income statement

Latest · FY2026
106.27M CAD
Year-over-year change
+588.5%

Other Income / Expenses vs competitors

How ACB.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +521.3% is the highest of 8, against a peer median of +60.5%.
  • Other income / expenses amounts to 30.1% of revenue for ACB.TO, versus a peer median of 14.7%.
ACB.TO Competitors
Other Income / Expenses for ACB.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$95.89M CAD+521.3%—30.1%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$67M CAD+65.1%—24.4%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$10.6M CAD+210.4%—6.7%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$479.91K USD+108.4%—0.9%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-$2.71M USD-29.7%—5.3%
EDT.TOSpectral Medical Inc.LTM Mar 2026-CA$26.64M CAD-164.5%—964.8%
TSND.TOTerrAscend Corp.LTM Mar 2026-$38.41M USD-16.3%—14.7%
WEED.TOCanopy Growth CorporationLTM Mar 2026-CA$189.78M CAD+60.5%—61.0%
Peer median (excluding ACB.TO) —+60.5%—14.7%

Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M233.29M270.28M343.29M320.59M
Cost of Revenue200.11M297.65M138.82M155.69M303.89M
Gross Profit21.23M(64.36M)131.46M187.61M16.7M
Gross Margin9.6%-27.6%48.6%54.6%5.2%
Research & Development10.39M6.56M3.57M3.68M4.02M
Selling, General & Admin188.99M183.4M156.88M166.47M173.5M
Operating Expenses252.67M189.96M177.91M182.66M179.5M
Depreciation & Amortization93.66M43.57M33.07M22.55M14.19M
EBITDA(1.55B)(210.74M)(12.34M)51.35M(162.79M)
EBITDA Margin-702.4%-90.3%-4.6%15.0%-50.8%
Operating Income(231.45M)(254.32M)(46.45M)4.95M(162.79M)
Operating Margin-104.6%-109.0%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.85M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(41.1M)(13.15M)15.43M106.27M
Income Before Tax(1.72B)(295.42M)(59.6M)20.38M(56.52M)
Pre-Tax Margin-777.1%-126.6%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)(20.32M)(554K)4.62M2.1M
Net Income(1.72B)(265.33M)(69.33M)1.59M(121.76M)
Net Margin-776.0%-113.7%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

TSX:ACB.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.